QbD Product Portfolio consists of early stage and clinical ready assets ready for partnership/registration across Biotechnology/Plasma/Pharmaceuticals:

a. Biotech Products – Early Stage

Rituximab
Infliximab
Denosumab
GCSF
Peg-GCSF

b. Biotech Products – Late Stage

EPO
GCSF
Peg-GCSF
Monoclonal antibodies
Vaccines

c. CAR-NK cells

PDL-1
PSCA
CD19/CD22

d. Plasma & Critical Care Products

Remdesivir
Albumin
IVIG
Factor-VIII
Factor – IX
PCC

e. Export

Pharmaceuticals
Biotechnology
Medical Devices
Nutraceuticals